Skip to main content
Back to Journal Club
Bleeding Complications with NOACs in Dermatologic Surgery

Fahmy LM, Dowd ML, Loesch E, et al.
Dermatol Surg (2023)

JC: February 2024

This study evaluated bleeding complications associated with novel oral anticoagulants (NOACs/DOACs) in dermatologic surgery. The analysis compared bleeding rates in patients on various NOACs versus those not on anticoagulation, providing evidence to guide perioperative anticoagulation management for dermatologic surgical procedures including Mohs surgery.

Take-Home Messages

  • •NOACs are associated with increased but generally manageable bleeding complications in dermatologic surgery.
  • •Continuation of NOACs through dermatologic surgery is generally recommended to avoid thromboembolic risk from interruption.
  • •Meticulous hemostasis techniques and pressure dressings are the primary management strategies for NOAC-related intraoperative bleeding.
PubMed →DOI →

Topic

Hemostasis & Anticoagulation

TXA, anticoagulation management, bleeding complications

Abstract

Novel oral anticoagulants (NOACs) are commonly prescribed, recently developed anticoagulants, but limited data exist on NOAC-related bleeding complications in Mohs micrographic surgery (MMS). To assess the risk of postoperative bleeding in patients taking NOACs compared with patients taking no antithrombotic medications. A 5-year retrospective chart review of all MMS cases performed by a single surgeon was conducted. Patient and surgery characteristics, anticoagulant use, and bleeding complic...

View on PubMedDOI
Literature review only. This summary is an editorial interpretation and may not reflect the complete findings of the original publication. Always refer to the full-text article for clinical decision-making.